-+ 0.00%
-+ 0.00%
-+ 0.00%

Reckitt invests up to $600 million to expand US R&D and OTC manufacturing footprint

PUBT·09/16/2026 10:04:10
Listen to the news
Reckitt invests up to $600 million to expand US R&D and OTC manufacturing footprint
  • Reckitt Benckiser Group plc launched a multi-year U.S. expansion plan with up to USD 600 million in investment.
  • New Jersey campus to consolidate North American commercial operations with R&D, adding a new science and innovation center.
  • North Carolina OTC plant budget increased 50%, targeting higher output for Mucinex and Move Free; opening planned for H1 2027.
  • Program targets faster product development, improved U.S. supply resilience, expanded access to healthcare products.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Reckitt Benckiser Group plc published the original content used to generate this news brief on September 16, 2026, and is solely responsible for the information contained therein.